Karine Aguera

Title: The Innovative Contributions of Karine Aguera

Introduction

Karine Aguera is a prominent inventor based in Lyons, France. She has made significant strides in the field of cancer treatment through her innovative research and development. Her work focuses on a novel method for treating both liquid and solid cancers, showcasing her dedication to advancing medical science.

Latest Patents

Karine Aguera holds a patent for a method of treating a mammal, including humans, against cancer using methionine and asparagine depletion. The invention involves administering methioninase before asparaginase, which is a groundbreaking approach in cancer therapy. Additionally, her invention encompasses the use of dietary methionine deprivation, potentially combined with methioninase administration, prior to asparaginase treatment. Methioninase and asparaginase can be utilized in various forms, including free form, pegylated form, or encapsulated into erythrocytes. This patent highlights her innovative approach to cancer treatment and her commitment to improving patient outcomes.

Career Highlights

Karine Aguera is associated with Erytech Pharma, a company dedicated to developing innovative treatments for cancer. Her role at Erytech Pharma has allowed her to collaborate with other talented professionals in the field, further enhancing her contributions to medical research.

Collaborations

Some of her notable coworkers include Willy Berlier and Fabien Gay. Their collaboration has fostered an environment of innovation and creativity, leading to advancements in cancer treatment methodologies.

Conclusion

Karine Aguera's contributions to cancer treatment through her innovative patent demonstrate her commitment to improving healthcare. Her work at Erytech Pharma and collaborations with esteemed colleagues further solidify her position as a leading inventor in the medical field.